TY - JOUR
T1 - A national survey of state medicaid psychotropic-monitoring programs targeting youths
AU - DosReis, Susan
AU - Tai, Ming Hui
AU - Camelo, Wendy Castillo
AU - Reeves, Gloria
PY - 2016/10/1
Y1 - 2016/10/1
N2 - Objective: This study aimed to describe state Medicaid psychotropic-monitoring programs targeting youths. Methods: Key informants from each state Medicaid administration and the District of Columbia were invited to participate in a telephone-administered survey designed to assess the implementation strategies of the state psychotropic-monitoring program. Data were collected from August 2011 through December 2012. A total of 38 states participated, four declined, and nine did not respond to the invitation. Descriptive statistics were used to characterize monitoring programs. Results: Key informants from 28 of the 38 states (74%) reported a program in place, mostly prior authorization (68%). One-third of the programs (32%) had a two-tier review involving pharmacists and child psychiatrists. Conclusions: Although variability in psychotropic-monitoring programs may limit comparison of program impact across states, the variability provides an opportunity to investigate the impact of different models on best practices and the quality of care.
AB - Objective: This study aimed to describe state Medicaid psychotropic-monitoring programs targeting youths. Methods: Key informants from each state Medicaid administration and the District of Columbia were invited to participate in a telephone-administered survey designed to assess the implementation strategies of the state psychotropic-monitoring program. Data were collected from August 2011 through December 2012. A total of 38 states participated, four declined, and nine did not respond to the invitation. Descriptive statistics were used to characterize monitoring programs. Results: Key informants from 28 of the 38 states (74%) reported a program in place, mostly prior authorization (68%). One-third of the programs (32%) had a two-tier review involving pharmacists and child psychiatrists. Conclusions: Although variability in psychotropic-monitoring programs may limit comparison of program impact across states, the variability provides an opportunity to investigate the impact of different models on best practices and the quality of care.
UR - http://www.scopus.com/inward/record.url?scp=84989890622&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84989890622&partnerID=8YFLogxK
U2 - 10.1176/appi.ps.201500270
DO - 10.1176/appi.ps.201500270
M3 - Review article
C2 - 27133725
AN - SCOPUS:84989890622
VL - 67
SP - 1146
EP - 1148
JO - Hospital and Community Psychiatry
JF - Hospital and Community Psychiatry
SN - 1075-2730
IS - 10
ER -